Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Type

Guidance programme 5 selected

Guidance programme

HealthTech approach

HealthTech approach

Area of interest

Showing 1 to 10 of 1249

TitleReference numberPublishedLast updated
Netarsudil for treating open-angle glaucoma or ocular hypertension (terminated evaluation)TA1180
Lutetium-177 vipivotide tetraxetan for treating PSMA-positive hormone-relapsed metastatic prostate cancer after an anti-androgen but not a taxane (terminated evaluation)TA1179
Deuruxolitinib for treating severe alopecia areataTA1178
Pembrolizumab with chemoradiotherapy for untreated locally advanced cervical cancerTA1177
Cemiplimab for treating recurrent or metastatic cervical cancer that has progressed on or after platinum-based chemotherapyTA1174
Glycopyrronium bromide cream for treating severe primary axillary hyperhidrosisTA1175
Teplizumab for delaying the onset of stage 3 type 1 diabetes in people 8 years and over with stage 2 type 1 diabetesTA1176
Heavy menstrual bleeding: assessment and managementNG88
Pirtobrutinib for treating relapsed or refractory chronic lymphocytic leukaemia after a BTK inhibitorTA1173
Advanced breast cancer: diagnosis and treatmentCG81

Results per page

  1. 10
  2. 25
  3. 50
  4. All